Golgi-impregnated horizontal cells (HCs) as viewed in whole mount human retinas have been studied by light microscopic (LM) techniques. Impregnated HCs have been drawn by camera lucida and by the Eutectics neuron tracing method to provide quantitative data on dendritic tree sizes, dendritic tree shapes, and dendritic terminals for statistical treatment and cluster analysis. In addition, fractal analyses of HC dendritic branching patterns have been performed. Three significantly different HCs can be classified on both subjective and objective morphological criteria in central and peripheral human retina. In the fovea all HCs are so small that it is difficult to achieve a clear separation of the subtypes, although they can be distinguished by the experienced observer. HI types are the classic HCs of Polyak (The Retina, Chicago: University of Chicago Press, 1941) with distinct dendritic terminal clusters going to cones and a fan-shaped axon terminal consisting of large numbers of rod-destined terminals. HII cells have profusely branched, overlapping dendrites, with poorly defined terminals going to cones and a short curled axon bearing small terminals also going to cones. The HIII types exhibit larger diameter, more asymmetrically shaped dendritic trees and 30% more dendritic terminal clusters than HI cells at any location on the retina. Many HIII cells appear to emit a process from the cell body in the inner nuclear layer (INL) that descends into the outer strata of the inner plexiform layer (IPL). The axon of the HIII cell may end in a loosely organized, sprawling arborization. Fractal dimensions of the horizontal cells also show significant differences between the three groups. HII cells exhibit the highest fractal dimension followed by HI and HIII cells with lower and lowest fractal dimensions, respectively. The fractal dimension of HII cells of rhesus monkey, as determined from drawings by other authors in other publications, are the same as HII cells of human retina.

G-quadruplex DNA-specific ligands were generated using a combinatorial selection of tetrapeptides which were then conjugated to a hemicyanine scaffold. The heterocycle enhanced peptide binding affinity by approximately 1000-fold to give ligands with near micromolar affinity and >40-fold discrimination for quadruplex DNA over duplex.

No abstract

We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in 177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals who do not seroconvert even weeks after infection. They are younger than seroconverters who have increased co-morbidity and higher inflammatory markers such as C-Reactive Protein. Higher antibody responses are associated with non-white ethnicity. Antibody responses do not decline during follow up almost to 2 months. Serological assays increase understanding of disease severity. Their application in regular surveillance will clarify the duration and protective nature of humoral responses to SARS-CoV-2.

The molecular target for the bacteriolytic E protein from bacteriophage wX174, responsible for host cell lysis, is known to be the enzyme phospho-MurNAc-pentapeptide translocase (MraY), an integral membrane protein involved in bacterial cell wall peptidoglycan biosynthesis, with an essential role being played by peptidyl-prolyl isomerase SlyD. A synthetic 37 aa peptide E pep , containing the N-terminal transmembrane a-helix of E, was found to be bacteriolytic against Bacillus licheniformis, and inhibited membrane-bound MraY. The solution conformation of E pep was found by circular dichroism (CD) spectroscopy to be 100 % a-helical. No change in the CD spectrum was observed upon addition of purified Escherichia coli SlyD, implying that SlyD does not catalyse prolyl isomerization upon E. However, E pep was found to be a potent inhibitor of SlyD-catalysed peptidylprolyl isomerization (IC 50 0?15 mM), implying a strong interaction between E and SlyD. E pep was found to inhibit E. coli MraY activity when assayed in membranes (IC 50 0?8 mM); however, no inhibition of solubilized MraY was observed, unlike nucleoside natural product inhibitor tunicamycin. These results imply that the interaction of E with MraY is not at the MraY active site, and suggest that a protein-protein interaction is formed between E and MraY at a site within the transmembrane region.